Corona-Hernández LE, Jiménez-Chobillon MA, Peña-Mirabal ES

Language: Spanish
References: 32
Page: 119-130
PDF size: 449.65 Kb.

ABSTRACT

Background: The nasosinusal polyposis is the result of a chronic inflammatory process characterized by a cellular infiltration of eosino glanphils, which collaborate often to pathologies such as asthma; nevertheless, other cellular types are also involved in its physiopathology as neutrophils which have different clinical behavior, being necessary specific treatments.
Objective: To describe and to characterize the leukocitary compartment in patients with nasosinusal polyposis of the National Institute of Respiratory Diseases of Mexico, and to identify cases of nasosinusal polyposis with neutrophil not syndromic predominance.
Material and Method: A retrospective, cross-sectional, observational and comparative study of absolute and percentage eosinophil and neutrophil quantification was made in samples obtained from 123 patients submitted to endoscopic surgery due to nasosinusal polyposis diagnosis. Clinical characteristics of patients with nasosinusal polyposis were identified by reviewing clinical records, splitting into 4 groups in accordance with histological characteristics and association to syndromes.
Results: 27 (22%) patients were identified with neutrophilic infiltration more than 60%; while 96 (78%) patients had eosinophilic predominance more than 60%. In the analysis of logistic regression statistical interrelation was not found between the quantity of eosinophils and neutrophils with the clinical recurrence (p=0.649 in the group with syndromic eosinophilic predominance and p=0.756 in the group with not syndromic neutrophilic predominance).
Conclusions: There was not found statistical difference between the type of predominant leukocitary compartment respect to recurrence and presurgical endoscopic degree, which suggests that it is necessary to measure the proinflammatory factors.

REFERENCES

1. Bachert C, Gevaert P, Holtappels G, et al. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001;107:607-614.

2. García Cruz ML, Jiménez-Chobillon MA, Teran LM. Rhinosinusitis and aspirin-exacerbated respiratory disease. J Allergy 2012;2012: 273752.

3. Peters A, Kato A, Zhang N, et al. Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 2010;125:397-403.

4. Cheng W, Zheng C, Tian J. T helper cell population and eosinophilia in nasal polyps. J Investig Allergol Clin Immunol 2007:17:297-301.

5. Lacroix JS, Zheng CG, Goytom SH, et al. Histological comparison of nasal polyposis in black African, Chinese and Caucasian patients. Rhinology 2002;40:118-121.

6. Ikeda K, Shiozawa A, Ono N, et al. Subclassification of chronic rhinosinusitis with nasal polyp based on eosinophil and neutrophil. Laryngoscope 2013;123:1-9.

7. Kirtsreesakul V. Update on nasal polyps: etiopathogenesis. J Med Assoc Thai 2005;88:1966-1972.

8. Pawankar R. Nasal polyposis: an update: editorial review. Curr Opin Allergy Clin Immunol 2003;3:1-6.

9. Jeong WJ, Lee CH, Cho SH, Rhee CS. Eosinophilic allergic polyp: a clinically oriented concept of nasal polyp. Otolaryngol Head Neck Surg 2010;144:241-246.

10. Van Zele T, Claeys S, Geavert P, Van Maele G, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006:61:1280-1289.

11. Stevens WW, Schleimer RP, Chandra RK, Peters AT. Biology of nasal polyps. J Allergy Clin Immunol 2014:133:1503.

12. Wen W, Liu W, Zhang L, Bai J, et al. Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy. J Allergy Clin Immunol 2012;129:1522-1528.

13. Yamamoto H, Okamoto Y, Horiguchi S, Kunii N, et al. Detection of natural killer T cells in the sinus mucosa from asthmatics with chronic sinusitis. Allergy 2007:62:1451-1455.

14. Zhang N, Van Zele T, Perez-Novo C, Van Bruaene N, et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol 2008:122:961-968.

15. Wang de Y. Significance of susceptible gene expression profiles in nasal polyposis. Clin Exp Otorhinolaryngol 2008;1:177-183.

16. Steinke JW, Payne S, Borish L. Factors driving the aspirin exacerbated respiratory disease phenotype. Am J Rhinol Allergy 2015:29:35-40.

17. Mullol J, Picado C. Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease. Immunol Allergy Clin N Am 2013:33;163-176.

18. Tan B, Li QZ, Suh L, Kato A, et al. Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 2011:128:1198-1206.

19. Hoiby N, Koch C, Spencer D. Cystic fibrosis: with special reference to respiratory infections. Ryan DW (ed.) Current Practice I Critical Illness. London: Arnold, 1999;15-43.

20. Tecimer H, Kasapoglu F, Demir U, Ozmen O, et al. Correlation between clinical findings and eosinophil/neutrophil ratio in patients with nasal polyps. Eur Arch Otorhinolaryngology 2015;272:915-921.

21. Rostkowska B, Kapral M, Fraczek M, Kowalczyk M, et al. A microarray study of gene expression profiles in nasal polyps. Auris Nasus Larynx 2011;38:58-64.

22. Shinkai M, Henke MO, Rubin BK. Macrolide antibiotics as immunomodulatory medications: proposed mechanism of action. Pharmacol Ther 2008;117:393-405.

23. Harvey RJ, Wallwork BD, Lund VJ. Anti-inflammatory effects of macrolides: applications in chronic rhinosinusitis. Immunol Allergy Clin North Am 2009;29:689-703.

24. Van Zele T, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol 2010;125:1069-1076.

25. Sakuma Y, Ishitoya J, Komatsu M, Shiono O, et al. New clinical diagnostic criteria for eosinophilic chronic rhinosinusitis. Auris Nasus Larynx 2011;38:583-588.

26. Culic O, Erakovic V, Parnham M. Anti-inflammatory effects of macrolide antibiotics. Eur J Pharmacol 2001;429:209- 229.

27. Yamada T, Fujeda S, Mori S, Yamamoto H, Saito H. Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. Am J Rhinol 2000;14:143-148.

28. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: developing guidance for clinical trials. Otolaryngol Head Neck Surg 2006;135:31-80.

29. Shin SH, Ye MK, Kim JK, Cho CH. Histological characteristics of chronic rhinosinusitis with nasal polyps: recent 10-year experience of a single center in Daegu, Korea. Am J Rhinol Allergy 2014;28:95-98.

30. Humes K, Jones N, Ramírez R. Overview of race and hispanic origin: 2010. U.S. Census Bureau 2010.

31. Payne S, Borish L, Steinke JW. Genetics and phenotyping in chronic sinusitis. J Allergy Clin Immunol 2011;128:710-720.

32. Wang S, Lewis C, Jakobsson M, Ramachandran S, et al. Genetic variation and population structure in native Americans. PLoS Genet 2007;3:185.